Zydus receives tentative approval from the USFDA for Bosentan Tablets for Oral Suspension

Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration to market Bosentan Tablets for Oral Suspension, 32 mg.

Related Keywords

Ahmedabad ,Gujarat ,India ,United States , ,Zydus Lifesciences ,Drug Administration ,Bosentan Tablets ,Lifesciences Limited ,United States Food ,Oral Suspension ,Zydus Lifesciences Limited ,Zyduslifesciences ,Ine010b01027 ,Usfda ,Tentativeapproval ,Bosentantablets ,Oralsuspension ,